|
|
|
|
| The development of protein therapeutics faces critical challenges, from cell cloning inefficiencies to ensuring quality. Join our webinar to see how you can revolutionize your protein therapeutics development. See how the integration of VIPS® PRO technology and InstiGRO™ CHO supplements is setting new benchmarks in cloning success, enhancing both efficiency and quality in protein therapeutics. Ready to revolutionize your production methods? Join us to lead the change in protein therapeutics development. Register Now |
|
|
|
|
By Steve Fawell, AstraZeneca | Progress with PROTACs and molecular glues hasn’t come without challenges, particularly in identifying the right chemistry starting point for drug development — a process known as hit discovery. This article looks at the role of CRISPR, screening assays, and more. |
|
|
|
|
| Cell Culture Supplements To Accelerate Stable Cell Line Development | Application Note | By Dan Jones, Nicola Latchem, Andrea Gough, Camilla Domeneghetti, and Emma Morris, Advanced Instruments, Inc. | Review this demonstration where animal component-free Insti CHO and HEK cell culture supplements enable the industry to overcome cell culture limitations while meeting regulatory requirements. |
|
|
|
|
| COGs Process Economics For Autologous Cell Therapy | White Paper | Cytiva | Analyze the cost distribution over time for autologous CAR T therapy manufacturing using process economics and additional insights. Discover how cell therapy manufacturers can combat these costs. |
|
|
|
|
| Quality Versus Quantity In T Cell Production | Article | Terumo BCT | As more T cell therapies come to market, the quality and scale of treatments are set to improve further. See how technological advances have made it possible to produce high-quality T cells at scale. |
|
|
| Understanding Potency In Gene Therapy Development | White Paper | Bio-Rad Laboratories, Inc. | Explore the importance of understanding potency in cell and gene therapy (CGT) development and the challenges in developing potency assays for CGT products. |
|
|
| How Level Of Touch Guides Clinical Trial Tools And Methods | Article | By Dr. Graham Wylie, MRN - Medical Research Network | To run clinical studies quickly, safely, and with high data integrity, it's effective to assess trials by degree of touch. Discover how different trial types are suited to the application of different tools and methods. |
|
|
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|